Big Pharma’s Patent Abuses Are Fueling the Drug Pricing Crisis
The latest in news from I-MAK experts.
For press inquiries, please contact simon@i-mak.org.
Patent abuse driving high drug prices, non-profit claims
Brainstorm Health: BeiGene IPO, Amerisource CEO on Amazon, California Data Privacy Law
Axios Vitals: Patents = profits (Article 3)
Report: Hundreds of Patents on America’s Top Selling Drugs are Triggering Price Hikes and Blocking Competition
AbbVie faces hepatitis C patent challenge in India
Brief: AbbVie Hepatitis C Treatment Patents Challenged In India For Evergreening
Conceptualizing Minimum Core Beyond Affordable Goods And Services – Trade For Human Rights As A Minimum Core Obligation
I-MAK & Patients for Affordable Drugs File Amicus Brief with the US Supreme Court in support of RPX Corp in RPX Corp. v. Chanbond LLC
I-MAK & Delhi Network of Positive People File Opposition to Prevent AbbVie Patent Grant on Hepatitis C Treatment
Fed. Circ.’s PTAB Standing Rule Flouts Law, Justices Hear